Line 27: |
Line 27: |
| *Vaccination sets up memory to the viral infection | | *Vaccination sets up memory to the viral infection |
| | | |
− | *High levels of cytotoxic T cells and neutralising antibody are activated in 1-2 days as a secondary response (instead of 4-10 days as a primary response) | + | *High levels of [[T cell differentiation - WikiBlood#Cytotoxic T-Cells|cytotoxic T cells]] and neutralising [[Immunoglobulins - WikiBlood|antibody]] are activated in 1-2 days as a [[B cell differentiation - WikiBlood#Secondary T Cell Dependent Response|secondary response]] (instead of 4-10 days as a [[B cell differentiation - WikiBlood#T-Cell Dependent Response|primary response]]) |
| | | |
| *The infection is therefore prevented from taking hold causing lesions to develop | | *The infection is therefore prevented from taking hold causing lesions to develop |
| | | |
− | *Neutralising antibody blocks the attachment of virus to host cells receptors | + | *Neutralising [[Immunoglobulins - WikiBlood|antibody]] blocks the attachment of virus to host cells receptors |
| | | |
− | *'''Endogenous vaccines''' are where the antigen are made as new proteins by the cell, bacterium or virus | + | *'''Endogenous vaccines''' are where the [[Adaptive Immune System - WikiBlood#Antigen Recognition|antigen]] are made as new proteins by the cell, bacterium or virus |
− | **Involves MHC class I processing | + | **Involves [[MHC - WikiBlood#MHC I|MHC class I]] processing |
| **E.g. live virus, recombinant virus and DNA vaccines | | **E.g. live virus, recombinant virus and DNA vaccines |
| | | |
− | *'''Exogenous vaccines''' are when the antigen is processed from the outside by endocytosis without any new proteins being made by the host cell | + | *'''Exogenous vaccines''' are when the [[Adaptive Immune System - WikiBlood#Antigen Recognition|antigen]] is processed from the outside by endocytosis without any new proteins being made by the host cell |
− | **involves MHC class II processing | + | **involves [[MHC - WikiBlood#MHC II|MHC class II]] processing |
| **E.g. Inactivated and subunit vaccines | | **E.g. Inactivated and subunit vaccines |
| | | |